Covid-19 and Birth Outcome in Infants

ABSTRACT

Background: Severe acute respiratory syndrome coronavirus 2 (SARSCoV‐2), was identified as the causative pathogen of pneumonia cases. The vulnerability of pregnant women and their offspring is well established from the results of prior coronavirus outbreaks. Past human coronavirus outbreaks have shown us that pregnant women and their unborn offspring are particularly susceptible to adverse effects. This study was conducted to look for the maternal and neonatal outcome in COVID-positive mothers. Methods: We retrospectively analyzed their medical data. We used the Coronavirus Pneumonia Prevention's criteria as per guidelines. All of these patients had their throats sampled, and the samples were sent to the lab. Medical records were gathered and independently examined for clinical traits, lab test outcomes, and maternal and neonatal outcomes. Results: Mean age in study group was 26.42±5.26 while in control group was 27.5±7.2 (p=0.3282). in study group complications during pregnancy was 48 (88.89%) while in control group it was 31 (28.18%) (P<0.0001). LSCS was performed in 50 (92.59%) and 85(77.27%) in study group and control group respectively. Preterm delivery was observed in 8(14.81%) in the study group while it was 5(4.55%). Previous morbid conditions were observed in 5(9.26%) in the study group while it was 15(13.64%).. “Key neonatal markers, such as gestational age at birth, the APGAR score at five minutes, and intrauterine fetal distress, did not significantly differ between newborns from the cases and controls”. In this study, we looked for evidence that COVID-19 pneumonia among pregnant women who underwent vaginal or caesarean birth causes significant maternal and newborn problems. The results of laboratory tests had the same profile as pregnant women without pneumonia.